<?xml version='1.0' encoding='utf-8'?>
<document id="24632962"><sentence text="Changing prescription pattern of omeprazole among patients receiving clopidogrel."><entity charOffset="33-43" id="DDI-PubMed.24632962.s1.e0" text="omeprazole" /><entity charOffset="69-80" id="DDI-PubMed.24632962.s1.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.24632962.s1.e0" e2="DDI-PubMed.24632962.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s1.e0" e2="DDI-PubMed.24632962.s1.e1" /></sentence><sentence text="Recent studies have suggested that omeprazole may reduce the inhibitory effect of clopidogrel on platelet aggregation"><entity charOffset="35-45" id="DDI-PubMed.24632962.s2.e0" text="omeprazole" /><entity charOffset="82-93" id="DDI-PubMed.24632962.s2.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.24632962.s2.e0" e2="DDI-PubMed.24632962.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s2.e0" e2="DDI-PubMed.24632962.s2.e1" /></sentence><sentence text=" The United States Food and Drug Administration (FDA) has issued an update regarding this drug-drug interaction" /><sentence text=" This study aimed to evaluate the changing prescription pattern of omeprazole in patients taking clopidogrel after the FDA update regarding the clopidogrel-omeprazole interaction"><entity charOffset="67-77" id="DDI-PubMed.24632962.s4.e0" text="omeprazole" /><entity charOffset="97-108" id="DDI-PubMed.24632962.s4.e1" text="clopidogrel" /><entity charOffset="144-166" id="DDI-PubMed.24632962.s4.e2" text="clopidogrel-omeprazole" /><pair ddi="false" e1="DDI-PubMed.24632962.s4.e0" e2="DDI-PubMed.24632962.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s4.e0" e2="DDI-PubMed.24632962.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24632962.s4.e0" e2="DDI-PubMed.24632962.s4.e2" /><pair ddi="false" e1="DDI-PubMed.24632962.s4.e1" e2="DDI-PubMed.24632962.s4.e1" /><pair ddi="false" e1="DDI-PubMed.24632962.s4.e1" e2="DDI-PubMed.24632962.s4.e2" /></sentence><sentence text=" A pharmacy database system was used to identify all prescriptions of clopidogrel alone, clopidogrel and omeprazole, or clopidogrel and ranitidine from May 1, 2009 until May 31, 2010"><entity charOffset="70-81" id="DDI-PubMed.24632962.s5.e0" text="clopidogrel" /><entity charOffset="89-100" id="DDI-PubMed.24632962.s5.e1" text="clopidogrel" /><entity charOffset="105-115" id="DDI-PubMed.24632962.s5.e2" text="omeprazole" /><entity charOffset="120-131" id="DDI-PubMed.24632962.s5.e3" text="clopidogrel" /><entity charOffset="136-146" id="DDI-PubMed.24632962.s5.e4" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e0" e2="DDI-PubMed.24632962.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e0" e2="DDI-PubMed.24632962.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e0" e2="DDI-PubMed.24632962.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e0" e2="DDI-PubMed.24632962.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e0" e2="DDI-PubMed.24632962.s5.e4" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e1" e2="DDI-PubMed.24632962.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e1" e2="DDI-PubMed.24632962.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e1" e2="DDI-PubMed.24632962.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e1" e2="DDI-PubMed.24632962.s5.e4" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e2" e2="DDI-PubMed.24632962.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e2" e2="DDI-PubMed.24632962.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e2" e2="DDI-PubMed.24632962.s5.e4" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e3" e2="DDI-PubMed.24632962.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24632962.s5.e3" e2="DDI-PubMed.24632962.s5.e4" /></sentence><sentence text="A total of 2,899 prescriptions were entered into the final data analysis" /><sentence text=" There was a statistically significant drop in omeprazole prescription with clopidogrel from 46"><entity charOffset="47-57" id="DDI-PubMed.24632962.s7.e0" text="omeprazole" /><entity charOffset="76-87" id="DDI-PubMed.24632962.s7.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.24632962.s7.e0" e2="DDI-PubMed.24632962.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s7.e0" e2="DDI-PubMed.24632962.s7.e1" /></sentence><sentence text="6% in the period before the FDA update to 38" /><sentence text="2% after the update (P = 0" /><sentence text="0037)" /><sentence text=" In addition, a significant increase was observed in the ranitidine prescription from 9"><entity charOffset="57-67" id="DDI-PubMed.24632962.s11.e0" text="ranitidine" /></sentence><sentence text="7% to 20" /><sentence text="1% during the same time frame (P = 0" /><sentence text="0059) without any significant change between the two study periods for those on clopidogrel alone without any protective gastrointestinal bleeding drug (43% versus 41"><entity charOffset="80-91" id="DDI-PubMed.24632962.s14.e0" text="clopidogrel" /></sentence><sentence text="7%)" /><sentence text=" On the other hand, of the 732 patients who were on clopidogrel and omeprazole during the period before the FDA update, 396 patients (54"><entity charOffset="52-63" id="DDI-PubMed.24632962.s16.e0" text="clopidogrel" /><entity charOffset="68-78" id="DDI-PubMed.24632962.s16.e1" text="omeprazole" /><pair ddi="false" e1="DDI-PubMed.24632962.s16.e0" e2="DDI-PubMed.24632962.s16.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s16.e0" e2="DDI-PubMed.24632962.s16.e1" /></sentence><sentence text="1%) were taken off omeprazole, 274 (37"><entity charOffset="19-29" id="DDI-PubMed.24632962.s17.e0" text="omeprazole" /></sentence><sentence text="4%) were kept on both drugs, 59 (8" /><sentence text="1%) had their omeprazole switched to ranitidine after the FDA update, and 3 patients were lost to follow-up (0"><entity charOffset="14-24" id="DDI-PubMed.24632962.s19.e0" text="omeprazole" /><entity charOffset="37-47" id="DDI-PubMed.24632962.s19.e1" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.24632962.s19.e0" e2="DDI-PubMed.24632962.s19.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s19.e0" e2="DDI-PubMed.24632962.s19.e1" /></sentence><sentence text="4%)" /><sentence text=" The present findings indicate a significant change in prescription pattern for omeprazole after the FDA update by taking patients off omeprazole or to a lesser extent replacing it with ranitidine"><entity charOffset="80-90" id="DDI-PubMed.24632962.s21.e0" text="omeprazole" /><entity charOffset="135-145" id="DDI-PubMed.24632962.s21.e1" text="omeprazole" /><entity charOffset="186-196" id="DDI-PubMed.24632962.s21.e2" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.24632962.s21.e0" e2="DDI-PubMed.24632962.s21.e0" /><pair ddi="false" e1="DDI-PubMed.24632962.s21.e0" e2="DDI-PubMed.24632962.s21.e1" /><pair ddi="false" e1="DDI-PubMed.24632962.s21.e0" e2="DDI-PubMed.24632962.s21.e2" /><pair ddi="false" e1="DDI-PubMed.24632962.s21.e1" e2="DDI-PubMed.24632962.s21.e1" /><pair ddi="false" e1="DDI-PubMed.24632962.s21.e1" e2="DDI-PubMed.24632962.s21.e2" /></sentence><sentence text="" /></document>